Language
English
Publication Date
5-1-2024
Journal
JACC: Heart Failure
DOI
10.1016/j.jchf.2024.02.020
PMID
38583167
Abstract
This review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society of Cardiology (ESC) guideline, the 2022 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Failure Society of America (HFSA) guideline, and the 2023 focused update of the 2021 ESC document. Overall, these guidelines aim to solidify significant advances throughout the HF continuum since the publication of previous full guideline iterations (2013 and 2016 for the ACC/AHA and ESC, respectively). All guidelines provide new recommendations for an increasingly complex landscape of HF care, with focus on primary HF prevention, HF stages, rapid initiation and optimization of evidence-based pharmacotherapies, overlapping cardiac and noncardiac comorbidities, device-based therapies, and management pathways for special groups of patients, including those with cardiac amyloidosis. Importantly, the ACC/AHA/HFSA document features special emphasis on HF risk prediction and screening, cost/value, social determinants of health, and health care disparities. The review discusses major similarities and differences between these recent guidelines and guideline updates, as well as their potential downstream implications for clinical care.
Keywords
Heart Failure, Humans, Practice Guidelines as Topic, Europe, United States, Cardiology, American Heart Association, Disease Management, Societies, Medical, comorbidities, guidelines, heart failure, pharmacotherapy, prevention, social determinants of health
Published Open-Access
yes
Recommended Citation
Ostrominski, John W; DeFilippis, Ersilia M; Bansal, Kannu; et al., "Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison" (2024). Faculty and Staff Publications. 4056.
https://digitalcommons.library.tmc.edu/baylor_docs/4056